CLINICAL_TRIALS
trial_result
· 2025-05-16
Clinical Trial Update: TGRX-678 Phase I Oral Pharmacokinetic Study [Phase 1]
Summary
A Phase I oral pharmacokinetic study of TGRX-678 for chronic myeloid leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shenzhen TargetRx Co., Ltd. | Conditions: Chronic Myeloid Leukemia | Phase 1 | Status: COMPLETED